What is IRON stock price today?

IRON (Disc Medicine Inc) stock is trading at $70.18 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is IRON stock going up or down today?

IRON stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy IRON stock now?

The decision to buy IRON depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is IRON a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for IRON based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is IRON stock overvalued or undervalued?

Use our DCF valuation calculator to determine if IRON is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is IRON's P/E ratio?

P/E ratio data for IRON will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is IRON's market cap?

IRON (Disc Medicine Inc) has a market capitalization of $2.69 billion, making it a small-cap stock.

What is IRON's price to book ratio?

IRON trades at a price-to-book (P/B) ratio of 3.53, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does IRON pay dividends?

IRON does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is IRON's dividend yield?

IRON does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is IRON stock a good long-term investment?

IRON's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is IRON's revenue growth rate?

Revenue growth data for IRON is available on our dashboard with detailed financial statement analysis.

Profitability metrics for IRON are available on our dashboard with complete income statement analysis.

What are the risks of investing in IRON?

Key risks for IRON include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does IRON compare to its competitors?

Compare IRON to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize IRON's performance and positioning.

What is IRON's stock price target for 2026?

Our AI model provides price targets for IRON based on fundamental analysis: Bull case $91.23 (+30%), Base case $80.71 (+15%), Bear case $63.16 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about IRON?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for IRON. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is IRON's next earnings report?

IRON reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

IRON - Disc Medicine Inc

NYSE * Health Care * Biotechnology

$70.18

$-0.30 (-0.43%)

About Disc Medicine Inc

Disc Medicine, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases in the United States. The company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, primarily heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for the treatment of erythropoietic porphyrias, including erythropoietic protoporphyria, X-linked protoporphyria, and diamond-blackfan anemia; DISC-0974 for the treatment of anemia of myelofibrosis, and anemia of chronic kidney disease; and DISC-3405 for the treatment of polycythemia vera, and other hematologic disorders. It also develops preclinical programs include DISC-0998, for the treatment of anemia associated with inflammatory diseases. The company was founded in 2017 and is headquartered in Watertown, Massachusetts.

IRON Key Statistics

Market Cap

$2.69B

P/B Ratio

3.53

EPS

$-6.01

Employees

155

How IRON Compares to Peers

IRON is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

N/A

of 5

Growth Rank

N/A

of 5

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
IRON(This stock)	$2.69B	N/A	0%	0.0%	-
AMGNAmgen Inc	$189.19B	24.7	0%	0.2%	vs AMGN
GILDGilead Sciences	$174.33B	20.7	0%	0.3%	vs GILD
VRTXVertex Pharmaceuticals	$113.01B	29.0	0%	0.3%	vs VRTX
REGNRegeneron Pharmaceuticals	$79.87B	18.2	0%	0.3%	vs REGN
BIIBBiogen Inc	$26.50B	20.5	-0%	0.1%	vs BIIB

Disc Medicine Inc Company Information

Headquarters: Massachusetts; U.S.A
Website: www.discmedicine.com
Sector: Health Care
Industry: Biotechnology

IRON - Disc Medicine Inc

About Disc Medicine Inc

IRON Key Statistics

How IRON Compares to Peers

Disc Medicine Inc Company Information

IRON Lician Score

IRON Financial Snowflake

Upcoming Events for IRON